eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk..
new research shows a growing number of young people are thinking about taking their own lives, and the study suggests school stress may play a role..
his heart, beating for 84 years and full of love for the woman he affectionately called his "blue-eyed guera [pronounced whedda]," felt like it was failing..
the media are there to give credibility to society and its structures. that�s why they�re called �major� instead of �minor.�.
.